Genovia Plus Pharmaceuticals Private Limited
Founded in 2015 and headquartered in Uttar Pradesh, India.
2015 | Varanasi, Uttar Pradesh (India) | Active
Genovia Plus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 87.93%
- Profit Growth 89.49%
- Ebitda 96.74%
- Net Worth 53.99%
- Total Assets 29.01%
About Genovia Plus Pharmaceuticals
Genovia Plus Pharmaceuticals Private Limited (GPPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 September 2015 (Nine years and five months 7 days old ). Its registered office is in Varanasi, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Singh and Gudiya Singh serve as directors at the Company.
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85191UP2015PTC073429
- Company No.
073429
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2015
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Healthcare
Who are the key members and board of directors at Genovia Plus Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Singh  | Director | 21-Sep-2015 | Current |
| Gudiya Singh | Director | 24-May-2019 | Current |
Financial Performance of Genovia Plus Pharmaceuticals.
Genovia Plus Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 87.93% increase. The company also saw a substantial improvement in profitability, with a 89.49% increase in profit. The company's net worth Soared by an impressive increase of 53.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genovia Plus Pharmaceuticals?
Unlock access to Genovia Plus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- D.R Dn Singh Multispeciality Hospital Private Limited
Manish Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genovia Plus Pharmaceuticals?
Unlock and access historical data on people associated with Genovia Plus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genovia Plus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genovia Plus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
